KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medtronic (MDT) Cash from Operations (2016 - 2026)

Medtronic's Cash from Operations history spans 13 years, with the latest figure at 2744000000.0 for Q1 2026.

  • For Q1 2026, Cash from Operations rose 6.69% year-over-year to 2744000000.0; the TTM value through Jan 2026 reached 7285000000.0, changed 0.11%, while the annual FY2025 figure was 7044000000.0, 3.79% up from the prior year.
  • Cash from Operations for Q1 2026 was 2744000000.0 at Medtronic, up from 925000000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 2777000000.0 in Q2 2024 and bottomed at 661000000.0 in Q4 2023.
  • The 5-year median for Cash from Operations is 1574000000.0 (2023), against an average of 1700705882.35.
  • The largest annual shift saw Cash from Operations tumbled 47.88% in 2022 before it skyrocketed 57.18% in 2024.
  • A 5-year view of Cash from Operations shows it stood at 922000000.0 in 2022, then dropped by 28.31% to 661000000.0 in 2023, then surged by 44.93% to 958000000.0 in 2024, then decreased by 3.44% to 925000000.0 in 2025, then surged by 196.65% to 2744000000.0 in 2026.
  • Per Business Quant, the three most recent readings for MDT's Cash from Operations are 2744000000.0 (Q1 2026), 925000000.0 (Q4 2025), and 1088000000.0 (Q3 2025).